FACCINI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.049
EU - Europa 839
AS - Asia 385
OC - Oceania 1
SA - Sud America 1
Totale 2.275
Nazione #
US - Stati Uniti d'America 1.038
GB - Regno Unito 347
CN - Cina 226
SE - Svezia 101
SG - Singapore 88
FR - Francia 72
RU - Federazione Russa 68
FI - Finlandia 65
IE - Irlanda 62
DE - Germania 47
VN - Vietnam 38
IT - Italia 37
UA - Ucraina 17
BE - Belgio 11
TR - Turchia 11
CA - Canada 9
IN - India 9
KR - Corea 7
CH - Svizzera 2
DK - Danimarca 2
MX - Messico 2
PH - Filippine 2
PL - Polonia 2
RO - Romania 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
NL - Olanda 1
PE - Perù 1
PT - Portogallo 1
SI - Slovenia 1
Totale 2.275
Città #
Southend 287
Chandler 207
Jacksonville 203
Ann Arbor 127
Woodbridge 101
Singapore 73
Dublin 62
Ashburn 47
Lancaster 46
Dong Ket 38
Beijing 37
Houston 30
Wilmington 26
Lawrence 25
Princeton 25
New York 23
Nanjing 19
Boardman 18
Hebei 17
Helsinki 17
Haikou 13
Jinan 13
Shenyang 13
Brussels 11
Changsha 11
Munich 10
Jiaxing 8
Ningbo 7
Seoul 7
Taiyuan 7
Zhengzhou 7
Milan 6
Nanchang 6
Tianjin 6
Toronto 6
Kent 5
Rome 5
Verona 5
Dongguan 4
Falls Church 4
Hangzhou 4
Redwood City 4
Santa Clara 4
Clearwater 3
Leawood 3
Mumbai 3
Phoenix 3
Redmond 3
Sindelfingen 3
Washington 3
Augusta 2
Bangalore 2
Bassano Del Grappa 2
Boston 2
Dallas 2
Florence 2
Guangzhou 2
Lanzhou 2
Los Angeles 2
Manila 2
Mexico City 2
Moscow 2
Novokuznetsk 2
Riva 2
Seattle 2
Secaucus 2
Shanghai 2
Taizhou 2
Victoria 2
Zurich 2
Ardabil 1
Atlanta 1
Belfast 1
Changle 1
Chaoyang 1
Chengdu 1
Chicago 1
Copenhagen 1
Dearborn 1
Den Haag 1
Düsseldorf 1
Edinburgh 1
Fairfield 1
Fuzhou 1
Hanover 1
Kemerovo 1
Las Vegas 1
Lima 1
Ljubljana 1
London 1
Melbourne 1
Monmouth Junction 1
Montreal 1
Newark 1
Noceto 1
Qingdao 1
San Francisco 1
San Mateo 1
Shenzhen 1
Stockholm 1
Totale 1.685
Nome #
11beta-hydroxysteroid dehydrogenase type-2 and type-1 (11beta-HSD2 and 11beta-HSD1) and 5beta-reductase activities in the pathogenia of essential hypertension 139
Acute hyperhomocysteinemia induces a reduction in arterial distensibility and compliance 116
Elevated plasma fibrinogen levels in patients with essential hypertension are related to vascular complications. 111
A genetic risk factor for vascular disease which leads to mild hyperhomocysteinemia is common in northern Italy. 111
High sodium intake is associated with increased glucocorticoid production, insulin resistance and metabolic syndrome. 111
Hyperhomocysteinemia and mortality after coronary artery by-pass grafing. 107
Genetic and environmental determinants of hyperhomocysteinemia in subjects with angiographically proven coronary artery disease 101
Genetic and eviromental determinants of hyperhomocysteinemia in subjects with corocary artery disease 93
Low circulating vitamin B6 markers of inflammation, and risk of coronary artery disease. 93
Biochemical and genetic markers of iron status and the risk of coronary disease 90
Determinants of platelet activation in human essential hypertension 88
Correlation between homocysteine plasma levels and nailfold videocapillaroscopic patterns in systemic sclerosis. 88
Acquired and genetic determinants of homocysteine in atheromatous renel artery stenosis with mild renal insufficiency 88
Low vitamin B6, markers of inflammation, and risk of coronary artery disease. 88
Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women. 88
Effects of Provocholine and metacholine on airway responses. 85
MTHFR C677T genotype-specific thresold values of folate status able to induce mild hyperhomocysteinemia. 85
Homocysteine plasma concentration is related to severity of lung impairment in scleroderma. 84
Severity of lung impairment in scleroderma is related to homocysteine plasma concentration. 83
The MTHFR/folate/Homocysteine connectio as a model of global gene-enviromental interaction with possible implication for the risk of coronary artery disease. 81
Urinary cortisol to cortisone metabolites ratio in prednisone-treated and spontaneously hypertensive patients 81
Increased urinary glucocorticoid metabolites are associated with metabolic syndrome, hypoadiponectinemia, insulin resistance and beta-cell dysfunction. 78
Glucose-induced alterations of intracellular ionized magnesium in human lymphocytes. 76
The interaction between MTHFR 677C>T genotype and folate status is a determinant of coronary atherosclerosis risk. 65
A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: Relationships with C677T polymorphism and homocysteine/folate metabolism 61
Totale 2.291
Categoria #
all - tutte 7.193
article - articoli 3.854
book - libri 0
conference - conferenze 3.339
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.386


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020199 0 0 0 0 36 30 36 26 5 32 8 26
2020/2021257 22 27 10 20 29 23 3 25 22 5 32 39
2021/2022229 36 64 0 25 7 6 4 11 7 3 18 48
2022/2023521 34 79 40 85 58 116 1 37 59 1 6 5
2023/2024217 12 19 21 15 17 41 3 11 0 14 35 29
2024/2025201 33 29 26 100 13 0 0 0 0 0 0 0
Totale 2.291